Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases
Open Access
- 30 July 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Lipids in Health and Disease
- Vol. 12 (1), 117
- https://doi.org/10.1186/1476-511x-12-117
Abstract
Background Early preclinical diagnosis of COPD is urgent. We proposed that fatty acid composition of red blood cells may serve as a prognostic test for the complications in the chronic respiratory diseases. Fatty acid composition of the erythrocyte membranes in patients with chronic respiratory diseases (chronic bronchitis, CB, and stable chronic obstructive pulmonary disease, COPD) was studied. It was established that modification of the fatty acid composition in the erythrocyte membranes was unidirectional in both groups of patients. Methods Patients with CB and stable COPD (group A, GOLD 1) (15 subjects in each group) were studied in clinic. The activity of the inflammatory process was evaluated by the phagocytic activity of neutrophils, cytokine levels and cytokine receptors in the blood serum (TNFα, sTNF-RI, bFGF, TGF-β, IL-8). Fatty acid (FA) composition of the erythrocyte membranes was analyzed by gas liquid chromatography. Statistical data processing was performed by the methods of descriptive statistics with Statistica 6.0. Results In both groups (CB and COPD), a significant accumulation of the saturated FAs (14:0, 15:0, 18:0) was established. The amount of the arachidonic acid (20:4n-6) was increased by 13% (р < 0.05) in CB patients and by 41% (р < 0.001) in COPD patients, as compared with healthy persons. The elevated level of the PUFA n-6 in the erythrocytes membranes in patients with chronic respiratory diseases confirms that proinflammatory (leukotriene B4) and bronchospasm (prostaglandin D2) mediator substrates is increased. The level of the eicosapentaenoic acid (20:5n-3) was decreased by 32% (р < 0.05) in CB patients and 2-fold (р < 0.001) in COPD patients. The observed increase in the 20:4n-6/20:5n-3 ratio - 1.5-fold (р < 0.001) in CB patients and 3-fold in COPD patients - can be a specific marker of the adverse course of the respiratory pathology and the chronic inflammatory development. Conclusions Chronic respiratory disease development is associated with the disturbance of the fatty acid composition in erythrocyte membranes and disbalance of the ratio between precursor of pro- and antiinflammatory eicosanoids.Keywords
This publication has 32 references indexed in Scilit:
- Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Lipids of Erythrocyte Membranes of COPD Patients: A Quantitative and Qualitative StudyCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2012
- Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndromeLipids in Health and Disease, 2011
- The cytokine network in asthma and chronic obstructive pulmonary diseaseJCI Insight, 2008
- Association of fatty acids in serum phospholipids with lung function and bronchial hyperresponsiveness in adultsEuropean Journal of Epidemiology, 2008
- Endogenous lipid mediators in the resolution of airway inflammationEuropean Respiratory Journal, 2007
- Airway inflammation in chronic obstructive pulmonary disease: Comparisons with asthmaJournal of Allergy and Clinical Immunology, 2003
- Lipid rafts and B-cell activationNature Reviews Immunology, 2002
- The natural history of chronic airflow obstruction.BMJ, 1977
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959